Abstract:Background: Preeclampsia is a significant pregnancy disorder with an unknown cause, mainly attributed to impaired spiral arterial remodeling. Methods: Using RNA sequencing, we identified key genes in placental tissues from healthy individuals and preeclampsia patients. Placenta and plasma samples from pregnant women were collected to detect the expression of TPBG (trophoblast glycoprotein). Pregnant rats were injected with TPBG-carrying adenovirus to detect preeclamptic features. HTR-8/SVneo cells transfected with a TPBG overexpression lentiviral vector were used in cell function experiments. The downstream molecular mechanisms of TPBG were explored using RNA sequencing and single-cell RNA sequencing data. TPBG expression was knocked down in the lipopolysaccharide-induced preeclampsia-like rat model to rescue the preeclampsia features. We also assessed TPBG's potential as an early preeclampsia predictor using clinical plasma samples. Results: TPBG emerged as a crucial differentially expressed gene, expressed specifically in syncytiotrophoblasts and extravillous trophoblasts. Subsequently, we established a rat model with preeclampsia-like phenotypes by intravenously injecting TPBG-expressing adenoviruses, observing impaired spiral arterial remodeling, thus indicating a causal correlation between TPBG overexpression and preeclampsia. Studies with HTR-8/SVneo cells, chorionic villous explants, and transwell assays showed TPBG overexpression disrupts trophoblast/extravillous trophoblast migration/invasion and chemotaxis. Notably, TPBG knockdown alleviated the lipopolysaccharide-induced preeclampsia-like rat model. We enhanced preeclampsia risk prediction in early gestation by combining TPBG expression with established clinical predictors. Conclusions: These findings are the first to show that TPBG overexpression contributes to preeclampsia development by affecting uterine spiral artery remodeling. We propose TPBG levels in maternal blood as a predictor of preeclampsia risk. The proposed mechanism by which TPBG overexpression contributes to the occurrence of preeclampsia via its disruptive effect on trophoblast and extravillous trophoblast migration/invasion on uterine spiral artery remodeling, thereby increasing the risk of preeclampsia.

ANGPTL4 Mediates the Protective Role of PPARγ Activators in the Pathogenesis of Preeclampsia

Angiotensin Receptor Agonistic Autoantibody-Mediated Tumor Necrosis Factor-Alpha Induction Contributes To Increased Soluble Endoglin Production In Preeclampsia

The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia

Laminin Α4 (LAMA4) Expression Promotes Trophoblast Cell Invasion, Migration, and Angiogenesis, and is Lowered in Preeclamptic Placentas.

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Upregulated LncZBTB39 in Pre-Eclampsia and Its Effects on Trophoblast Invasion and Migration Via Antagonizing the Inhibition of Mir-210 on THSD7A Expression.

PPARγ alleviates preeclampsia development by regulating lipid metabolism and ferroptosis

ANXA4 Promotes Trophoblast Invasion Via the PI3K/Akt/eNOS Pathway in Preeclampsia.

FOXP2 overexpression upregulates LAMA4 expression and thereby alleviates preeclampsia by regulating trophoblast behavior

Inhibition of HIF-1a-mediated TLR4 Activation Decreases Apoptosis and Promotes Angiogenesis of Placental Microvascular Endothelial Cells During Severe Pre-Eclampsia Pathogenesis

Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia

Peroxisome Proliferator-Activated Receptor Γ Mediates Porcine Placental Angiogenesis Through Hypoxia Inducible Factor-, Vascular Endothelial Growth Factor- and Angiopoietin-Mediated Signaling

Ligustrazine-induced Microrna-16-5p Inhibition Alleviates Preeclampsia Through IGF-2.

Gadd45 Alpha As An Upstream Signaling Molecule Of P38 Mapk Triggers Oxidative Stress-Induced Sflt-1 And Seng Upregulation In Preeclampsia

Dysregulated Expression of ACTN4 Contributes to Endothelial Cell Injury Via the Activation of the P38-Mapk/p53 Apoptosis Pathway in Preeclampsia

The neo-potential therapeutic strategy in preeclampsia: Downregulated miR-26a-2-3p motivates endothelial cell injury by targeting 15-LOX-1

G protein-coupled estrogen receptor stimulates human trophoblast cell invasion via YAP-mediated ANGPTL4 expression

Overexpressed Trophoblast Glycoprotein Contributes to Preeclampsia Development by Inducing Abnormal Trophoblast Migration and Invasion Toward the Uterine Spiral Artery

Preeclampsia Up-Regulates Angiogenesis-Associated Microrna (i.e., Mir-17, -20A, and -20B) That Target Ephrin-B2 and EPHB4 in Human Placenta.

Gadd45α As an Upstream Signaling Molecule of P38 MAPK Triggers Oxidative Stress-Induced Sflt-1 and Seng Upregulation in Preeclampsia.